Are We Drugging the Fish Instead of Cleaning the Tank? A Look at Ozempic and the State of American Health

Are we treating the symptoms or the disease? The rise of Ozempic, a diabetes drug now widely used for weight loss, has exposed the corrupted the American healthcare system.

The Problem Isn't a Lack of Ozempic, It's a Metabolic Health Crisis:

• Skyrocketing Rates: Obesity and pre-diabetes are rampant, affecting 42% and up to 33% of American adults, respectively. Amongst children the rates are increasing every year. These are signs of a deeper metabolic dysfunction, fueled by our environment and the food we consume. [CDC]
• Dirty Tank Analogy: Instead of addressing the root causes of this crisis (like unhealthy food policies, lack of access to nutritious options, and a sedentary lifestyle), we are being sold a pharmaceutical "solution" - a weekly injection that masks the problem instead of solving it.

Is Ozempic a Miracle Cure or a Risky Band-Aid?

• Gastrointestinal Issues: 30% of patients discontinue Ozempic within three months due to severe gastrointestinal problems, including stomach paralysis. Lawsuits are emerging over long-term digestive issues after stopping the drug. [USA Today] [Drugs.com]
• Mental Health Concerns: The EU has launched a probe into increased depression and suicidal ideation linked to Ozempic, potentially due to its impact on gut health (where 95% of serotonin is produced). [CNBC]
• Weight Regain: Most patients regain the weight they lost after stopping Ozempic, admitting its limitations as a long-term solution. [Indiana University School of Medicine]
• Profit Over Patients? Novo Nordisk, the maker of Ozempic, doesn't even promote the drug for obesity in Europe. They are heavily targeting the US market, capitalizing on our broken healthcare system. [Bloomberg]

Unmasking the Influence of Big Pharma:

• Conflicts of Interest: The American Academy of Pediatrics, despite a questionable 68-week study, recommends Ozempic as a first-line treatment for obese teens. [The Atlantic] It's alarming to note that many leading obesity experts, including those at Harvard, have received substantial payments from Novo Nordisk. [Reuters]
• Media Manipulation: Pharmaceutical companies are the largest spenders on TV news advertisements. This influence potentially stifles critical investigation into their practices and promotes a biased narrative favoring their products. [Johns Hopkins]
• Lobbying Power: Novo Nordisk has funded lobbying efforts, even through organizations like the NAACP, to promote Ozempic as a solution to obesity, framing opposition as a civil rights issue. [X/CalleyMeans]

We Need a Paradigm Shift in Healthcare:

• Prioritize Prevention: Focus on public health initiatives that promote healthy eating, exercise, and access to nutritious food. Rethink agricultural subsidies that disproportionately benefit processed food industries. [American Action Forum]
• Address Conflicts of Interest: Ban pharmaceutical companies from directly funding medical research and limit their influence on medical organizations and policymakers. Implement stricter conflict-of-interest guidelines for researchers and physicians.
• Empower Patients: Encourage a more holistic approach to health that emphasizes lifestyle changes and individualized care rather than relying solely on medication for symptom management.

We deserve a healthcare system that prioritizes our well-being, not corporate profits. Demand transparency, challenge the status quo, and advocate for a future where true health is attainable for all. Learn more about this critical issue and join the conversation from stellar science communicators like Calley Means , Robert Lufkin MD , Robert Lustig .

Enjoyed this article from The Information Upgrade!?

Please share, comment, and/or follow to read my perspective, get ahead of the week, and stay informed.

The Information Upgrade is available NOW on Substack. Early releases of new articles and sensitive topics will be published through Substack.

And, check this out before you go change the world: